How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,403 results for

Six Item Cognitive Impairment Test


Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Canadian stroke best practice recommendations: secondary prevention of stroke, sixth edition practice guidelines

A]. ii. Echocardiography should be considered in cases where a stroke mechanism has not been identified [Evidence Level C]. 1.3 Functional assessment i. Selected patients with transient ischemic attack or ischemic stroke should be assessed for neurological impairments and functional limitations when appropriate (e.g. cognitive evaluation, screening for depression, screening of fitness to drive, need for potential rehabilitation therapy, and assistance with activities of daily living), especially (...) for the Secondary Prevention of Stroke is a collection of current evidence-based recommendations intended for use by clinicians across a wide range of settings. The goal is to provide guidance for the prevention of ischemic stroke recurrence through the identification and management of modifiable vascular risk factors. Recommendations include those related to diagnostic testing, diet and lifestyle, smoking, hypertension, hyperlipidemia, diabetes, antiplatelet and anticoagulant therapies, carotid artery disease

2018 CPG Infobase

182. Cardiac arrhythmias in coronary heart disease

and is applicable to guidance produced using the processes described in SIGN 50: a guideline developer’s handbook, 2015 edition ( index.html). More information on accreditation can be viewed at accreditation Healthcare Improvement Scotland (HIS) is committed to equality and diversity and assesses all its publications for likely impact on the six equality groups defined by age, disability, gender, race, religion/belief and sexual orientation. SIGN guidelines (...) assessment of LV function for risk stratification at least six weeks following the acute event. 2.3 ARRHYTHMIAS ASSOCIATED WITH CHRONIC CORONARY HEART DISEASE/LEFT VENTRICULAR DYSFUNCTION R Rate control is the recommended strategy for management of patients with well-tolerated atrial fibrillation. R In patients with permanent AF or persistent AF following a rate-control strategy and a resting heart rate >110 bpm, appropriate rate-control therapy should be instituted with an initial target of resting

2018 SIGN

183. Management of stable angina

questionnaire using a set of common daily living items. 210 Simple exercise testing may further refine risk assessment. The failure to climb two flights of stairs, which is the equivalent of more than four METs, is a good predictor of mortality associated with thoracic surgery and complications after major non-cardiac surgery. 211 Cardiopulmonary exercise testing has been used to identify high-risk groups for major non-cardiac surgery. The measurement of anaerobic threshold may be a better predictor than (...) in SIGN 50: a guideline developer’s handbook, 2015 edition ( index.html). More information on accreditation can be viewed at accreditation Healthcare Improvement Scotland (HIS) is committed to equality and diversity and assesses all its publications for likely impact on the six equality groups defined by age, disability, gender, race, religion/belief and sexual orientation. SIGN guidelines are produced using a standard methodology that has been

2018 SIGN

184. Diagnosis and management of epilepsy in adults

but usually resolve with time. 126 Sedation may be less with AEDs licensed from, for example, 1990 onwards, particularly lamotrigine, oxcarbazepine and levetiracetam. 94 Many patients on long term AED therapy report cognitive adverse effects (see section 4.6.5) but studies to confirm this have been contradictory and confounded by the effects of chronic epilepsy. 142, 143 Polytherapy is probably associated with more cognitive adverse effects than monotherapy. 144 Impaired bone health is associated (...) be viewed at Healthcare Improvement Scotland (HIS) is committed to equality and diversity and assesses all its publications for likely impact on the six equality groups defined by age, disability, gender, race, religion/belief and sexual orientation. SIGN guidelines are produced using a standard methodology that has been equality impact assessed to ensure that these equality aims are addressed in every guideline. This methodology is set out in the current version of SIGN 50, our

2018 SIGN

185. What helps to support people affected by Adverse Childhood Experiences? A Review of Evidence

around’ 30 Continuity and Dependability – ‘they just leave you after a while’ 31 Flexibility and Control – ‘They don’t tell you what to do’ 32 4 Overview: Interventions to support people affected by Adverse Childhood Experiences (RoR) 33 4.1 Flow of literature through the review 33 4.2 Quality assessment 34 4.3 Best evidence synthesis 34 4.4 Classification of interventions 36 4.5 Summary and key findings 36 4.6 Findings 36 Cognitive Behavioural Therapy (CBT) 37 Psychological therapies other than (...) Cognitive Behavioural Therapy (CBT) 39 Psychoeducation 42 Treatments aimed predominately at parents 44 Parent / foster carer training 45 Cross-sector support 47 Educational 49 Housing and life skills 50 Foster care / out-of-home care 52 5 Stakeholder workshop 53 5.1 Findings 53 Inflexibility of school system and teachers’ attitudes 53 ACEs impact people in different ways and at different times 53 Ethnic background 54 Recreation and practical skills 54 Counselling and talking therapies 54 Ways to measure

2019 EPPI Centre

186. Public health service provision by community pharmacies: a systematic map of evidence

The included studies 88 9.3 Alcohol 88 9.4 Services for people who inject drugs 91 10 Obesity and weight management 98 10.1 Introduction 98 10.2 Included studies 98 11 Other health conditions 103 11.1 Introduction 103 11.2 Bowel disease and gastrointestinal conditions 106 11.3 Early cancer awareness 108 11.4 Chronic kidney disease (CKD) and renal impairment 112 11.5 Dementia and cognitive impairment 113 11.6 Depression 114 11.7 Low back pain 115 11.8 Migraine and headache 116 Public health service (...) health services via community pharmacies (n=15). The number of studies identified for each of these and other study foci are outlined in Figure 3.5. 1 1 1 1 1 1 1 2 2 2 4 7 9 12 Chronic kidney disorder (CKD) Dementia and cognitive impairment Depression Low back pain Migraine/headache Osteoarthritis Urinary tract infections (UTI) Skin disorders Sleep disorders Streptococcal infections Bowel disorders and GI conditions Cancer Respiratory health Osteoporosis Other health conditions The evidence-base

2019 EPPI Centre

187. Multimorbidity: a priority for global health research

complexes such as frailty or chronic pain. • Sensory impairment such as sight or hearing loss. • Alcohol and substance misuse.2.2 Challenges arising from a lack of consensus regarding definition It was clear from our evidence gathering that the diversity of terminology, multiplicity of definitions, and the inconsistency in how these terms and definitions are used, makes the scientific literature about multimorbidity difficult to navigate and assimilate. Inconsistent approaches to the definition

2018 Academy of Medical Sciences

188. Recommendations for the Delivery of Psychosocial Oncology Services in Ontario

emotional, psychological, cognitive and/ or spiritual distress have access to psychiatrists, social workers, psychologists, and/or spiritual care providers. 3.3 Patients experiencing physical, functional, rehabilitative, and/ or nutritional concerns have access to occupational therapists, physiotherapists, registered dietitians and/or speech language pathologists. 3.4 Regional Cancer Programs ensure continuity of care for all patients, regardless of where they receive their cancer treatment. 3.5 (...) population (10-13) . Their families and caregivers may also be affected by the disease, experiencing emotional and psychological distress, shifting roles, increasing responsibilities, financial burden and caregiver stress (14) (See Table 1 for a summary of patients’ and families’ psychosocial concerns). Category Concern Cognitive • Brain fog • Delirium • Preexisting and worsening cognitive issues (e.g., due to dementia, brain tumours • Capacity (consent to treatment and medical assistance in dying

2018 Cancer Care Ontario

189. Identifying Performance Measures, Indicators and Targets to Monitor and Evaluate Dementia Strategies

measures Indicators Targets Cuba (2103) (23) • Performance measures for the strategy (referred to as objectives in the strategy) include: 1) improve care for dementia patients and their families; 2) prevent cognitive impairment and dementia; 3) detect cognitive impairment early; 4) reduce stigma around dementia; 5) increase professional development; 6) train families in patient care; 7) promote basic, clinical and epidemiological research on dementia; and 8) familiarize health teams with laws (...) protecting the rights of older adults and people with cognitive impairment. • Indicators were divided by input (structure), process and outcomes indicators. 1) Input (structure) o existence of municipal memory clinic; o existence of a memory clinic in every polyclinic; o easy access to memory clinics and removal of architectural barriers in health centres; o existence of school for caregivers in each health area served by a polyclinic; o existence of senior centres for patients with mental incapacity

2018 McMaster Health Forum

190. Management of Cardiovascular Diseases during Pregnancy

and offspring complications 3174 3.3.3 Pregnancy heart team 3176 3.4 Cardiovascular diagnosis in pregnancy 3176 3.4.1 Electrocardiography 3176 3.4.2 Echocardiography 3176 3.4.3 Exercise testing 3177 3.4.4 Ionizing radiation exposure 3177 3.4.5 Chest radiography and computed tomography 3177 3.4.6 Cardiac catheterization 3177 3.4.7 Magnetic resonance imaging 3177 3.5 Genetic testing and counselling 3177 3.5.1 Pre-natal diagnosis 3178 3.6 Foetal assessment 3178 3.6.1 Screening for congenital heart disease 3178 (...) Ventricular tachycardia 3203 9.7 Bradyarrhythmias 3204 9.7.1 Sinus node dysfunction 3204 9.7.2 Atrioventricular block 3204 9.8 Interventions 3204 9.8.1 Electrical cardioversion 3204 9.8.2 Catheter ablation 3204 9.8.3 Implantable cardioverter-defibrillator and pacing 3204 9.9 Recommendations 3206 10. Hypertensive disorders 3207 10.1 Diagnosis and risk assessment 3207 10.1.1 Blood pressure measurement 3207 10.1.2 Laboratory tests 3207 10.2 Definition and classification of hypertension in pregnancy 3207 10.3

2018 European Society of Cardiology

191. International evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS)

One Screening, diagnostic assessment, risk assessment and life-stage 35 1.1 Irregular cycles and ovulatory dysfunction 36 1.2 Biochemical hyperandrogenism 38 1.3 Clinical hyperandrogenism 40 1.4 Ultrasound and polycystic ovarian morphology 42 1.5 Anti-Müllerian Hormone (AMH) 45 1.6 Ethnic variation 46 1.7 Menopause life-stage 47 1.8 Cardiovascular disease 48 1.9 Gestational diabetes, impaired glucose tolerance and type 2 diabetes 50 1.10 Obstructive sleep apnea 53 1.11 Endometrial cancer 55 (...) pharmacological agents 97 4.7 Inositol 99 Chapter Five Assessment and treatment of infertility 100 5.1a Assessment of factors that may affect fertility, treatment response or pregnancy outcomes 101 5.1b Tubal patency testing 103 5.2 Ovulation induction principles 104 5.3 Letrozole 105 5.4 Clomiphene citrate and/or metformin 107 5.5 Gonadotrophins 110 5.6 Anti-obesity agents 112 5.7 Laparoscopic ovarian surgery 113 5.8 Bariatric surgery 115 5.9a In-vitro fertilisation 117 5.9b Gonadotropin releasing hormone

2018 European Society of Human Reproduction and Embryology

192. Tools to aid the clinical identification of end of life

carried out in elderly patients in a geriatric acute ward. The CGA included clinical, cognitive, functional, nutritional and social parameters and was carried out using six standardised scales and information on medications and social support network, for a total of 63 items in eight domains. The development cohort included 838 and the validation cohort 857 elderly hospitalised patients. Crude mortality rate after a six-week follow-up was 10.6% (n=135). Prognostic factors identified were: malnutrition (...) predictors are included in the tool. Surprise question Other clinical subjective judgement Age Functional status Weight loss Frailty Clinical measures Emergency department presentations Hospital admissions Specific diseases present Specific conditions to which the tool applies. Dementia/cognitive impairment Deterioration Patient choice Other Evidence regarding clinical application Any evidence or description of how the tool has been applied in practice. TOOLS TO AID CLINICAL IDENTIFICATION OF END OF LIFE

2018 Sax Institute Evidence Check

193. Specialist dementia care units

Library, Dementia and Cognitive Improvement Group (DCIG) library, ALOIS: DCIG Study Register associated with Cochrane Library, Medline, CINAHL and PsycINFO. Details of the search terms and limiters used are included in Appendix A. Articles excluded during the title and abstract cull included the following: • Drug trials • Prevalence studies • Biological studies • Community-based studies • Mild dementia/cognitive impairment studies • Studies of general nursing home settings/populations • Incorrect (...) by searching the web using terms included in the academic literature search. Search engines used included, and The first 10 pages of each search were scanned and relevant articles identified by the brief summary. This provided 34 documents to review initially. Through a snowball search starting with these documents we then identified another 45 documents. An expert participant provided six extra items. The Department of Health forwarded an additional 46 grey literature

2018 Sax Institute Evidence Check

194. Dietary patterns and cardiovascular disease outcomes

) and recommendations, graded A–D, were established. For dietary patterns and primary prevention of CVD, four dietary patterns were investigated with six recommendations generated. The DASH, Dietary Approaches to Stop Hypertension, pattern received two Grade A recommendations for the primary prevention of CVD in relation to reductions in blood pressure and reduced risk of CVD events and/or mortality. Healthy/prudent diet was awarded a Grade B recommendation for reduction in risk associated with CVD events (...) ) were generated with three dietary patterns graded as Grade B (DASH, Vegetarian and Low-fat diet), five dietary patterns were rated as Grade C (Low GI/GL, Low carbohydrate, Mediterranean, High protein and Nordic/Tibetan diets). And one dietary pattern of Calorie-restricted diets was rated as Grade D. Overall, six dietary patterns were informed based on a single review. For seven dietary patterns (Low GI/GL, Low-fat diet, Low carbohydrate, Vegetarian diet, High protein, Calorie-restricted and Nordic

2018 Sax Institute Evidence Check

195. Optimisation of RIZIV – INAMI lump sums for incontinence

evaluation and management 40 2.4.6 Care pathway for the management of urine incontinence in men 41 2.4.7 Care pathway for the management of urine incontinence in women 45 2.5 MANAGEMENT OF URINARY INCONTINENCE IN THE FRAIL ELDERLY AND THE COGNITIVELY IMPAIRED 49 2.5.1 Conservative options 49 2.5.2 Pharmacological treatment 50 2.5.3 Surgical treatment in the frail older person 52 2.6 MANAGEMENT OF URINARY INCONTINENCE IN CHILDREN 56 2.6.1 Initial assessment 56 2.6.2 Initial management 57 2.6.3 Specialised (...) and severe dementia are individual risk factors for UI. Overflow of urine commonly presents when the bladder is continuously full, with or without weakening of the bladder muscles, and when there is no urge to urinate or bladder contractions. Predisposition factors for UI in men are less well documented in the literature and include presence of lower urinary tract symptoms (LUTS), urinary tract infections, functional and cognitive impairment, diabetes, neurological disorders, and surgery e.g

2019 Belgian Health Care Knowledge Centre

196. Fibromyalgia

no exercise or another intervention. Major outcomes were health-related quality of life (HRQL), pain intensity, stiffness, fatigue, physical function, withdrawals, and adverse 2017 6. Is cognitive behavioral therapy (CBT) an effective treatment for fibromyalgia ? Is cognitive behavioral therapy (CBT) an effective treatment for fibromyalgia ? Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work (...) : Fibromyalgia is a debilitating chronic disease characterized by musculoskeletal pain, fatigue, and compromises (...) in cognition. One of the biggest challenges surrounding fibromyalgia is proper diagnosis, as there is no current diagnostic test established. Most practitioners utilize examining tender points and other subjective self-assessments to aid in the assessment of the condition. Current therapies include both medication and non-pharmacologic such as chiropractic therapy, acupuncture, aerobic

2018 Trip Latest and Greatest

197. Trazodone

of the circadian clock contributes to cognitive decline. Rhythmicity is severely impaired in Alzheimer disease (AD) and few (...) therapeutic attempts succeeded in improving sleep disorders in such context. This study evaluated sleep parameters by actigraphy in 30 AD patients before and after trazodone use for 2 weeks, and we show a significant improvement in relative rhythm amplitude (RRA), compatible with a more stable daytime behavioral pattern. So, trazodone appears to produce a stabilization (...) is prescribed widely as a sleep aid, although it is indicated for depression, not insomnia. Its daytime cognitive and psychomotor effects have not been investigated (...) systematically in insomniacs. The primary goal of this study was to quantify, in primary insomniacs, the hypnotic efficacy of trazodone and subsequent daytime impairments. Sixteen primary insomniacs (mean age 44 years) participated, with insomnia confirmed by overnight polysomnography (sleep efficiency ≤ 85%). Trazodone 50 mg

2018 Trip Latest and Greatest

198. Statins for the primary prevention of cardiovascular events

, the Scandinavian Simvastatin Survival Study (the 4-S study), were reported. 13 Researchers tested simvastatin, sold by Merck as Zocor, on 4444 patients with high cholesterol and existing heart disease. After five years, the study concluded the patients saw a 35% reduction in their cholesterol, and their risks of dying from a myocardial infarction were reduced by 42%. At that moment several other pharmaceutical companies were developing similar products. Because of the high price, reimbursement of statins (...) the sample proportion is known (1/40 among subjects younger than 65 and 1/20 among subjects aged 65 years and older), this permits to extrapolate the data to the Belgian population. This extrapolation was realized thanks to the SAS survey procedure. To check the validity of this extrapolation we test the concordance of the extrapolated data with the official data published by RIZIV – INAMI. Concordance of the extrapolated data with RIZIV – INAMI data The exact number of users and the number of DDD’s

2019 Belgian Health Care Knowledge Centre

199. Identifying Effective Approaches to Support Parents and Caregivers of Children with Fetal Alcohol Spectrum Disorder

and therapy • One recent low-quality review aimed to identify programs targeted at families of children with physical disabilities and/or intellectual impairments and found education and counselling services delivered either online and in group settings as one possible approach.(7) • Two primary studies conducted in Ontario found Acceptance and Commitment Therapy (ACT) improved depression and stress among caregivers, reported health status, and psychological flexibility, as well as reduced cognitive (...) and disabilities resulting from alcohol exposure in utero.”(1) FASD affects fetal and brain development and may result in limitations to any of an individual’s: memory; sensory integration; social communication; language processing; emotional regulation; adaptive functioning; and other executive functions that may make conforming to social, behavioural and cognitive expectations difficult.(2; 3) These effects may mean that individuals affected by FASD are unable to live independently, have difficulty securing

2018 McMaster Health Forum

200. Managing health and wellbeing in the workplace

using selected key words within the advanced search functions of Google/Google Scholar and limited to the first 200 results in keeping with evidence-based guidance. Preferred Reporting Items for Systematic Reviews and Meta- Analyses (PRISMA) protocols were used with transparent reporting of search strategy and study retrieval (details in Appendices). 8 MANAGING HEALTH AND WELLBEING IN THE WORKPLACE| SAX INSTITUTE Evidence grading The review adopted the protocol used by the US Community Preventive (...) musculoskeletal disorders and symptoms, and moderate evidence that stakeholder participation and work modification are more effective and cost effective at returning to work adults with musculoskeletal conditions than other workplace-linked interventions. Evidence on the contribution of wellness programs to productivity is patchy. The Total Worker Health™(TWH) model has been used to develop the Employer Health and Productivity RoadMap™. The Roadmap comprises six interrelated and integrated core elements: (i

2018 Sax Institute Evidence Check

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>